Previous Close | 321.89 |
Open | 322.89 |
Bid | 326.83 x 800 |
Ask | 327.62 x 900 |
Day's Range | 322.20 - 327.78 |
52 Week Range | 215.96 - 335.83 |
Volume | |
Avg. Volume | 1,036,390 |
Market Cap | 85.554B |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | 16.28 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.64 (0.81%) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | N/A |
NASHVILLE, Tenn., May 10, 2024--HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference:
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
NASHVILLE, Tenn., April 26, 2024--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.